Plasma From Convalescent Donors Beneficial for COVID-19-Induced ARDS
Plasma with neutralizing antibody titer of at least 1:160 reduces mortality at 28 days versus standard care
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.